| Active substance |
Rizatriptan |
| Also known as |
Rizatriptan benzoate |
| Blood pressure |
Can cause transient increases |
| Chemical name |
N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine |
| Dosage (medical) |
5 mg or 10 mg tablets, typically at the onset of migraine symptoms, may repeat dose after 2 hours if needed, not to exceed 30 mg in a 24-hour period |
| Dosage (sports) |
Not applicable |
| Effects |
Relief from migraine headaches |
| Formula |
C15H19N5 |
| Half-life |
2-3 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Not routinely required |
| Main action |
Serotonin receptor agonist |
| Side effects |
Dizziness, drowsiness, fatigue, nausea, dry mouth, chest pain |
| Storage conditions |
Store at 15-30В°C (59-86В°F), keep away from moisture and light |
| Strength |
5mg |
| Substance class |
Triptan |
| Trade name |
Maxalt |
| Use in sports |
None |
| Water Retention |
Minimal to none |
| Manufacturer |
Cipla Ltd. |
| Packing |
4 tabs/blister |
